ArticleNature communications2025
Discovering the complete enhancer map of human herpesviruses using a natural language processing model.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Discovering the complete enhancer map of human herpesviruses using a natural language processing model.Nature communications · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Enhancers are distal cis-regulatory elements that dictate complex transcriptional repertoire. Herpes viruses exhibit programmed latent and lytic gene expression depending on the infected tissue and physiological state. Previously, using a systematic functional assay, we identified six enhancers within the genome of Kaposi's sarcoma-associated herpesvirus (KSHV). In this study, we present a natural language processing model (NLP)-based tool, ENHAvir, that is trained with these six enhancers and non-enhancer control sequences from the KSHV genome. ENHAvir identifies known enhancers and predicted novel enhancer elements in human herpesviruses. The activity of the predicted enhancers in HSV-2, HCMV, HHV-6, HHV-7, and EBV is confirmed in an enhancer reporter assay. The terminal repeats of all the herpes viruses also serve as a strong enhancer. Comparing herpesvirus enhancers with human enhancers reveals conserved enhancer signatures and the involvement of Alu elements. Here, we present an AI tool that successfully predicts enhancers in both viral and human genomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.